Skip to main content
Top
Published in: Cancer Causes & Control 6/2021

01-06-2021 | COVID-19 | Original Paper

Decreased public pursuit of cancer-related information during the COVID-19 pandemic in the United States

Authors: Siegfried Adelhoefer, Philipp Berning, Stephen B. Solomon, Majid Maybody, Seamus P. Whelton, Michael J. Blaha, Omar Dzaye

Published in: Cancer Causes & Control | Issue 6/2021

Login to get access

Abstract

Background

In response to the prioritization of healthcare resources towards the COVID-19 pandemic, routine cancer screening and diagnostic have been disrupted, potentially explaining the apparent COVID-era decline in cancer cases and mortality. In this study, we identified temporal trends in public interest in cancer-related health information using the nowcasting tool Google Trends.

Methods

We used Google Trends to query search terms related to cancer types for short-term (September 2019–September 2020) and long-term (September 2016–September 2020) trends in the US. We compared average relative search volumes (RSV) for specified time ranges to detect recent and seasonal variation.

Results

General search interest declined for all cancer types beginning in March 2020, with changes in search interest for “Breast cancer,” “Colorectal cancer,” and “Melanoma” of − 30.6%, − 28.2%, and − 26.7%, respectively, and compared with the mean RSV of the two previous months. In the same time range, search interest for “Telemedicine” has increased by + 907.1% and has reached a 4-year peak with a sustained increased level of search interest. Absolute cancer mortality has declined and is presently at a 4-year low; however, search interest in cancer has been recuperating since July 2020.

Conclusion

We observed a marked decline in searches for cancer-related health information that mirrors the reduction in new cancer diagnoses and cancer mortality during the COVID-19 pandemic. Health professions need to be prepared for the coming demand for cancer-related healthcare, foreshadowed by recovering interest in cancer-related information on Google Trends.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pennell NA, Dillmon M, Levit LA et al (2020) American Society of Clinical Oncology Road to Recovery Report: learning From the COVID-19 experience to improve clinical research and cancer care. J Clin Oncol 39:155–169 Pennell NA, Dillmon M, Levit LA et al (2020) American Society of Clinical Oncology Road to Recovery Report: learning From the COVID-19 experience to improve clinical research and cancer care. J Clin Oncol 39:155–169
2.
go back to reference Dai M, Liu D, Liu M et al (2020) Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10:783–791 Dai M, Liu D, Liu M et al (2020) Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov 10:783–791
3.
go back to reference Mei H, Dong X, Wang Y, Tang L, Hu Y (2020) Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan. Lancet Oncol 21:634–636 Mei H, Dong X, Wang Y, Tang L, Hu Y (2020) Managing patients with cancer during the COVID-19 pandemic: frontline experience from Wuhan. Lancet Oncol 21:634–636
4.
go back to reference Miyashita H, Mikami T, Chopra N et al (2020) Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol 31:1088–1089 Miyashita H, Mikami T, Chopra N et al (2020) Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol 31:1088–1089
5.
go back to reference Bashshur RL, Doarn CR, Frenk JM, Kvedar JC, Shannon GW, Woolliscroft JO (2020) Beyond the COVID pandemic, telemedicine, and health care. Telemed J e-Health 26:1310–1313 Bashshur RL, Doarn CR, Frenk JM, Kvedar JC, Shannon GW, Woolliscroft JO (2020) Beyond the COVID pandemic, telemedicine, and health care. Telemed J e-Health 26:1310–1313
7.
go back to reference Burki TK (2020) Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 21:629–630 Burki TK (2020) Cancer guidelines during the COVID-19 pandemic. Lancet Oncol 21:629–630
8.
go back to reference Sirintrapun SJ, Lopez AM (2018) Telemedicine in cancer care. Am Soc Clin Oncol Educ Book 38:540–545 Sirintrapun SJ, Lopez AM (2018) Telemedicine in cancer care. Am Soc Clin Oncol Educ Book 38:540–545
9.
go back to reference ASCO (2020) ASCO Special report: guide to cancer care delivery during the COVID-19 pandemic ASCO (2020) ASCO Special report: guide to cancer care delivery during the COVID-19 pandemic
10.
go back to reference Chen CC, Yamada T, Smith J (2014) An evaluation of healthcare information on the Internet: the case of colorectal cancer prevention. Int J Environ Res Public Health 11:1058–1075 Chen CC, Yamada T, Smith J (2014) An evaluation of healthcare information on the Internet: the case of colorectal cancer prevention. Int J Environ Res Public Health 11:1058–1075
11.
go back to reference Shim M, Kelly B, Hornik R (2006) Cancer information scanning and seeking behavior is associated with knowledge, lifestyle choices, and screening. J Health Commun 11(Suppl 1):157–172 Shim M, Kelly B, Hornik R (2006) Cancer information scanning and seeking behavior is associated with knowledge, lifestyle choices, and screening. J Health Commun 11(Suppl 1):157–172
12.
go back to reference Finney Rutten LJ, Agunwamba AA, Wilson P et al (2016) Cancer-related information seeking among cancer survivors: trends over a decade (2003–2013). J Cancer Educ 31:348–357 Finney Rutten LJ, Agunwamba AA, Wilson P et al (2016) Cancer-related information seeking among cancer survivors: trends over a decade (2003–2013). J Cancer Educ 31:348–357
13.
go back to reference Shea-Budgell MA, Kostaras X, Myhill KP, Hagen NA (2014) Information needs and sources of information for patients during cancer follow-up. Curr Oncol 21:165–173 Shea-Budgell MA, Kostaras X, Myhill KP, Hagen NA (2014) Information needs and sources of information for patients during cancer follow-up. Curr Oncol 21:165–173
14.
go back to reference Effenberger M, Kronbichler A, Shin JI, Mayer G, Tilg H, Perco P (2020) Association of the COVID-19 pandemic with Internet search volumes: a Google TrendsTM analysis. Int J Infect Dis 95:192–197 Effenberger M, Kronbichler A, Shin JI, Mayer G, Tilg H, Perco P (2020) Association of the COVID-19 pandemic with Internet search volumes: a Google TrendsTM analysis. Int J Infect Dis 95:192–197
15.
go back to reference Eysenbach G (2011) Infodemiology and infoveillance: tracking online health information and cyberbehavior for public health. Am J Prev Med 40:S154–S158 Eysenbach G (2011) Infodemiology and infoveillance: tracking online health information and cyberbehavior for public health. Am J Prev Med 40:S154–S158
16.
go back to reference Cook S, Conrad C, Fowlkes AL, Mohebbi MH (2011) Assessing Google flu trends performance in the United States during the 2009 influenza virus A (H1N1) pandemic. PLoS ONE 6:e23610 Cook S, Conrad C, Fowlkes AL, Mohebbi MH (2011) Assessing Google flu trends performance in the United States during the 2009 influenza virus A (H1N1) pandemic. PLoS ONE 6:e23610
17.
go back to reference Kandula S, Shaman J (2019) Reappraising the utility of Google Flu Trends. PLoS Comput Biol 15:e1007258 Kandula S, Shaman J (2019) Reappraising the utility of Google Flu Trends. PLoS Comput Biol 15:e1007258
18.
go back to reference Kumar N, Pandey A, Garg N, Sampene E, Lavie CJ (2018) Seasonal and geographic patterns in seeking cardiovascular health information: an analysis of the online search trends. Mayo Clin Proc 93:1185–1190 Kumar N, Pandey A, Garg N, Sampene E, Lavie CJ (2018) Seasonal and geographic patterns in seeking cardiovascular health information: an analysis of the online search trends. Mayo Clin Proc 93:1185–1190
19.
go back to reference Mavragani A (2020) Infodemiology and infoveillance: scoping review. J Med Internet Res 22:e16206 Mavragani A (2020) Infodemiology and infoveillance: scoping review. J Med Internet Res 22:e16206
20.
go back to reference Schootman M, Toor A, Cavazos-Rehg P et al (2015) The utility of Google Trends data to examine interest in cancer screening. BMJ Open 5:e006678 Schootman M, Toor A, Cavazos-Rehg P et al (2015) The utility of Google Trends data to examine interest in cancer screening. BMJ Open 5:e006678
21.
go back to reference Phillips CA, Barz Leahy A, Li Y, Schapira MM, Bailey LC, Merchant RM (2018) Relationship between state-level Google online search volume and cancer incidence in the United States: retrospective study. J Med Internet Res 20:e6 Phillips CA, Barz Leahy A, Li Y, Schapira MM, Bailey LC, Merchant RM (2018) Relationship between state-level Google online search volume and cancer incidence in the United States: retrospective study. J Med Internet Res 20:e6
22.
go back to reference Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. Cancer J Clin 70:7–30 Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. Cancer J Clin 70:7–30
24.
go back to reference Rosenkrantz AB, Prabhu V (2016) Public interest in imaging-based cancer screening examinations in the United States: analysis using a web-based search tool. AJR Am J Roentgenol 206:113–118 Rosenkrantz AB, Prabhu V (2016) Public interest in imaging-based cancer screening examinations in the United States: analysis using a web-based search tool. AJR Am J Roentgenol 206:113–118
25.
go back to reference Islami F, Goding Sauer A, Miller KD et al (2018) Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 68:31–54 Islami F, Goding Sauer A, Miller KD et al (2018) Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin 68:31–54
26.
go back to reference The LO (2020) Safeguarding cancer care in a post-COVID-19 world. Lancet Oncol 21:603 The LO (2020) Safeguarding cancer care in a post-COVID-19 world. Lancet Oncol 21:603
27.
go back to reference Giannakoulis VG, Papoutsi E, Siempos II (2020) Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data. JCO Glob Oncol 6:799–808 Giannakoulis VG, Papoutsi E, Siempos II (2020) Effect of cancer on clinical outcomes of patients with COVID-19: a meta-analysis of patient data. JCO Glob Oncol 6:799–808
28.
go back to reference Mehta V, Goel S, Kabarriti R et al (2020) Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov 10:935–941 Mehta V, Goel S, Kabarriti R et al (2020) Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov 10:935–941
29.
go back to reference Williamson EJ, Walker AJ, Bhaskaran K et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584:430–436 Williamson EJ, Walker AJ, Bhaskaran K et al (2020) Factors associated with COVID-19-related death using OpenSAFELY. Nature 584:430–436
30.
go back to reference Yu J, Ouyang W, Chua MLK, Xie C (2020) SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan. China JAMA Oncol 6:1108–1110 Yu J, Ouyang W, Chua MLK, Xie C (2020) SARS-CoV-2 transmission in patients with cancer at a tertiary care hospital in Wuhan. China JAMA Oncol 6:1108–1110
31.
go back to reference Lewis MA (2020) Between scylla and charybdis - oncologic decision making in the time of Covid-19. N Engl J Med 382:2285–2287 Lewis MA (2020) Between scylla and charybdis - oncologic decision making in the time of Covid-19. N Engl J Med 382:2285–2287
32.
go back to reference DeRosier J (2020) Sharp declines in new cancer diagnoses observed during COVID-19 pandemic DeRosier J (2020) Sharp declines in new cancer diagnoses observed during COVID-19 pandemic
33.
go back to reference Maringe C, Spicer J, Morris M et al (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21:1023–1034 Maringe C, Spicer J, Morris M et al (2020) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol 21:1023–1034
34.
go back to reference Sud A, Jones M, Broggio J et al (2020) Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol 31:1065–1074 Sud A, Jones M, Broggio J et al (2020) Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. Ann Oncol 31:1065–1074
36.
go back to reference Calabrò L, Peters S, Soria JC et al (2020) Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med 8:542–544 Calabrò L, Peters S, Soria JC et al (2020) Challenges in lung cancer therapy during the COVID-19 pandemic. Lancet Respir Med 8:542–544
37.
go back to reference Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F (2020) Testing for COVID-19 in lung cancer patients. Ann Oncol 31:832–834 Passaro A, Peters S, Mok TSK, Attili I, Mitsudomi T, de Marinis F (2020) Testing for COVID-19 in lung cancer patients. Ann Oncol 31:832–834
38.
go back to reference Paterson C, Bacon R, Dwyer R et al (2020) The role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer team: implications for practice. Semin Oncol Nurs 36:151090 Paterson C, Bacon R, Dwyer R et al (2020) The role of telehealth during the COVID-19 pandemic across the interdisciplinary cancer team: implications for practice. Semin Oncol Nurs 36:151090
Metadata
Title
Decreased public pursuit of cancer-related information during the COVID-19 pandemic in the United States
Authors
Siegfried Adelhoefer
Philipp Berning
Stephen B. Solomon
Majid Maybody
Seamus P. Whelton
Michael J. Blaha
Omar Dzaye
Publication date
01-06-2021
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 6/2021
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-021-01409-1

Other articles of this Issue 6/2021

Cancer Causes & Control 6/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine